Literature DB >> 33135773

Photosensitive Dermatitis Induced by Nivolumab/Ipilimumab Combination Therapy in a Patient with Malignant Melanoma.

Yuri Sakaguchi1, Takaya Komori, Megumi Aoki, Atsushi Otsuka, Kenji Kabashima, Shigeto Matsushita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33135773      PMCID： PMC9309830          DOI： 10.2340/00015555-3681

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  4 in total

Review 1.  A review of UVA-mediated photosensitivity disorders.

Authors:  E Smith; F Kiss; R M Porter; A V Anstey
Journal:  Photochem Photobiol Sci       Date:  2011-11-30       Impact factor: 3.982

2.  Mogamulizumab-induced photosensitivity in patients with mycosis fungoides and other T-cell neoplasms.

Authors:  Y Masuda; K Tatsuno; S Kitano; H Miyazawa; J Ishibe; M Aoshima; T Shimauchi; T Fujiyama; T Ito; Y Tokura
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-01-31       Impact factor: 6.166

3.  Phototoxic and photoallergic cutaneous drug reactions.

Authors:  Martin Glatz; Günther F L Hofbauer
Journal:  Chem Immunol Allergy       Date:  2012-05-03

4.  Chronic actinic dermatitis.

Authors:  Alexandria V Booth; Stephanie Mengden; Nicholas A Soter; David Cohen
Journal:  Dermatol Online J       Date:  2008-05-15
  4 in total
  2 in total

Review 1.  Anticancer treatments and photosensitivity.

Authors:  V Sibaud
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-06       Impact factor: 9.228

2.  Photosensitive rash induced by nivolumab.

Authors:  Francisco J Navarro-Triviño; Ricardo Ruiz-Villaverde
Journal:  An Bras Dermatol       Date:  2022-07-07       Impact factor: 2.113
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.